NV-ALDEC
Aldec, Inc. , a pioneer in mixed HDL language simulation and hardware-assisted verification solutions for system and ASIC designs, will present the spectrum of pre-silicon verification solutions at the DVCon Europe Conference and Exhibition to be held October 19-20, 2016 in Munich, Germany.
At DVCon Europe, Aldec will demonstrate industry-proven verification methodologies and solutions using a Network-on-Chip (NoC) design based on research conducted at Stanford University by Daniel Ulf Becker. “The NoC was built as a mesh topology with a configurable number of routers that provide device connection nodes,” illustrates Krzysztof Szczur, Aldec Hardware Verification Products Manager. “The network is able to transfer data packets between any pair of nodes and therefore can serve as the backbone of a complex System-on-Chip (SoC) ASIC design.”
“Verification of complex designs comprised of NoC structures requires a robust chain of verification methodologies such as static linting, high-performance HDL simulation/debugging, and emulation,” said Louie De Luna, Aldec Director of Marketing. “The Verification Spectrum begins as soon as the first lines of HDL code are available, where designers use static linting to catch common bugs and check code sanity. Then HDL simulation using a UVM Verification environment is completed to achieve the highest level of debugging with Structural and Functional Coverage. Finally, to shorten days or weeks of simulation runs, long test sequences of constrained-random testbenches can be accelerated using an emulator. With Aldec’s 35,000+ user community, Aldec is committed to support every stage of this process.”
Visitors to Aldec’s Booth #304 at DVCon Europe will have the opportunity to meet directly with Product Managers who will be on hand to demonstrate an NoC design example, illustrating a seamless verification approach that includes:
- Design source code linting and analysis with ALINT-PRO™ that provides a comprehensive library of pre-defined checking policies and unique visualization tools to improve design analysis and help understand violations that frequently lead to design bugs. Use of a linting solution within early design stages helps to minimize the number of subsequent synthesis & implementation re-runs, and simplifies code maintenance and re-use by keeping the RTL sources clean.
- HVL/HDL simulation with Riviera-PRO™ that combines the best-in-class simulation solution for VHDL, SystemVerilog and UVM with powerful debugging tools, including UVM Toolbox, UVM Graph and Class Viewer. Riviera-PRO has been designed to accompany engineers at every step of design and validation, from golden model through RTL to gate-level netlists and timing simulation.
- UVM simulation acceleration with the HES-DVM™ emulation and prototyping platform based on the largest Xilinx® Virtex-7™ and UltraScale™ FPGAs, which connect with Riviera-PRO (or third-party simulators) using Accellera® SCE-MI, the industry standard for simulation and emulation interoperability at the transaction level. Related White Paper: Designing UVM Testbench for Simulation and Emulation of Network-on-Chip Design .
About Aldec
Aldec Inc., headquartered in Henderson, Nevada, is an industry leader in Electronic Design Verification and offers a patented technology suite including: RTL Design, RTL Simulators, Hardware-Assisted Verification, SoC and ASIC Prototyping, Embedded, Design Rule Checking, CDC Verification, IP Cores, Requirements Lifecycle Management, DO-254 Functional Verification and Military/Aerospace solutions. www.aldec.com
Aldec is a registered trademark of Aldec, Inc. All other trademarks or registered trademarks are the property of their respective owners.
View source version on businesswire.com: http://www.businesswire.com/news/home/20161012005159/en/
Contact:
Aldec, Inc.
Christina Toole, 702-990-4400
christinat@aldec.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SINOVAC Announces Record and Distribution Dates for Special Cash Dividend30.4.2025 08:00:00 CEST | Press release
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that a special dividend of US$55.00 per common share, as previously announced on April 1, 2025, will be paid in cash to valid holders of SINOVAC’s common shares as of the close of business on May 23, 2025, ET. Such cash dividend is expected to be paid on or about July 9, 2025. About SINOVAC Sinovac Biotech Ltd. (SINOVAC) is a China-based biopharmaceutical company that focuses on the R&D, manufacturing, and commercialization of vaccines that protect against human infectious diseases. SINOVAC’s product portfolio includes vaccines against COVID-19, enterovirus 71 (EV71) infected hand-foot-mouth disease (HFMD), hepatitis A, varicella, influenza, poliomyelitis, pneumococcal disease, etc. The COVID-19 vaccine, CoronaVac®, has been approved for use in more than 60 countries and regions worldwide. The hepatitis A vaccine, Healive®, passed WHO prequalificat
SES: Q1 2025 Results30.4.2025 07:30:00 CEST | Press release
Solid Start to the Year SES S.A. announces financial results for the three months ended 31 March 2025. Revenue of €509 million (-0.5% yoy(1)) and Adjusted EBITDA(2) of €280 million (-0.9% yoy(1)), both growing excl. periodic impact Networks revenue up +8.4% yoy(1) including some periodic impact supported by growth in Government (+13.1% yoy(1)) and Mobility (+8.5% yoy(1)); Media (-10.6% yoy(1)) in-line with expectations €360 million of new business and contract renewals signed in Q1 2025 Net Leverage at 1.2x(3) (including cash & cash equivalents of €3.1 billion(4)) O3b mPOWER satellites 7&8 have reached final orbital position – boosting mPower network capacity and resilience from May FY 2025 financial outlook(5) on track with yoy stable Revenue and broadly stable Adjusted EBITDA re-affirmed Fully funded Intelsat acquisition anticipated to complete in H2 2025 – intention to optimise the combined debt structure On 3 April 2025, AGM approved all company recommended resolutions including pr
Geoswift Launches Visa Direct to Enhance Cross-Border Payment Offers in Over 30 Countries30.4.2025 03:00:00 CEST | Press release
Geoswift announced today the integration of Visa Direct with Geoswift's cross-border payments platform. Visa Direct facilitates payouts to more than 140 countries and territories. The integration will enable payouts in 32 countries and territories, across 13 currencies, covering major markets in Asia Pacific, North America, Europe and Middle East, with plans for more in the future. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250423288249/en/ Bryan Ma, SVP, Head of Geoswift Global Payments, and Swapnil Mhasde, Head of Visa Direct Commercialization and Solutions, Asia Pacific, celebrating the launch in Singapore. Geoswift is a leading provider of cross-border payment services and solutions globally. With over two decades of innovation, it has become a trusted name in B2B, education, eCommerce, remittance, and travel payment use cases. Raymond Qu, Group CEO of Geoswift, stated, "At Geoswift, our vision has always been to del
Logitech Announces Q4 and Full Fiscal Year 2025 Results29.4.2025 22:03:00 CEST | Press release
A Year of Broad-Based Sales Growth, Expanded Market Share and Increased Profitability, Driven by Strategic Priorities SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the fourth quarter and full Fiscal Year 2025 ended March 31, 2025. For Fiscal Year 2025: Sales were $4.55 billion, up 6 percent in US dollars and 7 percent in constant currency, compared to the prior year. GAAP operating income was $655 million, up 11 percent compared to the prior year. Non-GAAP operating income was $775 million, up 11 percent compared to the prior year. GAAP earnings per share (EPS) was $4.13, up 7 percent compared to the prior year. Non-GAAP EPS was $4.84, up 14 percent compared to the prior year. Cash flow from operations was $843 million. The year-ending cash balance was $1.5 billion. The Company returned $797 million of cash to shareholders through its annual dividend payment and share repurchases.
U.S. Patent and Trademark Office Invalidates Pharmacyclics Patent Asserted Against BeiGene29.4.2025 21:32:00 CEST | Press release
BeiGene, Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company that intends to change its name to BeOne Medicines Ltd., today announced that the U.S. Patent and Trademark Office (USPTO) rendered a Final Written Decision invalidating all claims of Pharmacyclics LLC’s (Pharmacyclics) U.S. Patent No. 11,672,803 (the ‘803 patent) that were challenged by BeiGene in a post-grant review (PGR) proceeding. On November 1, 2023, BeiGene filed a PGR petition with the USPTO challenging the validity of certain claims of the ‘803 patent, in response to a patent infringement lawsuit Pharmacyclics brought against BeiGene concerning BRUKINSA® (zanubrutinib). On May 1, 2024, the USPTO granted BeiGene’s petition to institute the PGR. The USPTO’s Final Written Decision is appealable by Pharmacyclics. Commenting on the ruling, BeiGene General Counsel Chan Lee said: “We are pleased that the USPTO invalidated all challenged claims of the ‘803 patent. Today’s decision reinforces our belief th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom